Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin for BK Virus in HIV-Associated Salivary Gland Disease
NCT02068846Phase 3Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ciprofloxacin in salivary gland disease (SGDs), sponsored by University of North Carolina at Chapel Hill. Started Apr 2014; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
salivary gland disease (SGDs)
Beyond the preview
Go deeper on NCT02068846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02068846.